title: Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
abstract: Telomeres are involved in maintaining genomic stability. Previous studies have linked both telomere length (TL) and telomere-related genes with cancer. We evaluated associations between telomere-related genes, TL, and breast cancer risk in an admixed population of US non-Hispanic white (1,481 cases, 1,586 controls) and U.S. Hispanic and Mexican women (2,111 cases, 2,597 controls) from the Breast Cancer Health Disparities Study. TL was assessed in 1,500 women based on their genetic ancestry. TL-related genes assessed were MEN1, MRE11A, RECQL5, TEP1, TERC, TERF2, TERT, TNKS, and TNKS2. Longer TL was associated with increased breast cancer risk [odds ratio (OR) 1.87, 95% confidence interval (CI) 1.38, 2.55], with the highest risk (OR 3.11, 95% CI 1.74, 5.67 p interaction 0.02) among women with high Indigenous American ancestry. Several TL-related single nucleotide polymorphisms had modest association with breast cancer risk overall, including TEP1 rs93886 (OR 0.82, 95% CI 0.70,0.95); TERF2 rs3785074 (OR 1.13, 95% CI 1.03,1.24); TERT rs4246742 (OR 0.85, 95% CI 0.77,0.93); TERT rs10069690 (OR 1.13, 95% CI 1.03,1.24); TERT rs2242652 (OR 1.51, 95% CI 1.11,2.04); and TNKS rs6990300 (OR 0.89, 95% CI 0.81,0.97). Several differences in association were detected by hormone receptor status of tumors. Most notable were associations with TERT rs2736118 (ORadj 6.18, 95% CI 2.90, 13.19) with estrogen receptor negative/progesterone receptor positive (ER-/PR+) tumors and TERT rs2735940 (ORadj 0.73, 95% CI 0.59, 0.91) with ER-/PR- tumors. These data provide support for an association between TL and TL-related genes and risk of breast cancer. The association may be modified by hormone receptor status and genetic ancestry.
authors: Department of Medicine, University of Utah, Salt Lake City, UT 84108, USA.
authors: Andrew J
authors: AJ
authors: Pellatt
authors: Roger K
authors: RK
authors: Wolff
authors: Gabriela
authors: G
authors: Torres-Mejia
authors: Esther M
authors: EM
authors: John
authors: Jennifer S
authors: JS
authors: Herrick
authors: Abbie
authors: A
authors: Lundgreen
authors: Kathy B
authors: KB
authors: Baumgartner
authors: Anna R
authors: AR
authors: Giuliano
authors: Lisa M
authors: LM
authors: Hines
authors: Laura
authors: L
authors: Fejerman
authors: Richard
authors: R
authors: Cawthon
authors: Martha L
authors: ML
authors: Slattery
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D005260:Female; D056726:Genetic Association Studies; D042822:Genomic Instability; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011960:Receptors, Estrogen / Q000235:genetics; D011980:Receptors, Progesterone / Q000235:genetics; D012307:Risk Factors; D019098:Telomerase / Q000235:genetics*; D016615:Telomere / Q000235:genetics*; D059505:Telomere Homeostasis / Q000235:genetics*
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C509186:TERT protein, human; D019098:Telomerase
references: Pathol Oncol Res. 2011 Sep;17(3):685-90
references: 21455637
references: Breast Cancer Res Treat. 2008 May;109(1):35-46
references: 17616810
references: Gut. 2012 Feb;61(2):248-54
references: 21708826
references: Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1238-50
references: 21467229
references: Urol Oncol. 2006 Mar-Apr;24(2):122-30
references: 16520276
references: Br J Cancer. 2007 Sep 17;97(6):832-6
references: 17848914
references: PLoS One. 2011;6(6):e20466
references: 21695195
references: Oncogene. 2009 Mar 19;28(11):1465-70
references: 19182824
references: J Invest Dermatol. 2009 Feb;129(2):415-21
references: 18668136
references: Breast Cancer Res. 2011 Jun 06;13(3):R56
references: 21645396
references: Clin Cancer Res. 2009 Dec 1;15(23):7429-33
references: 19934287
references: Cancer Res. 2011 Sep 1;71(17):5792-805
references: 21799032
references: Psychosom Med. 2011 Sep;73(7):541-7
references: 21597035
references: Breast Cancer Res Treat. 2010 Jul;122(2):395-407
references: 19847644
references: Aging Cell. 2009 Aug;8(4):405-13
references: 19493248
references: Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):28-34
references: 21102320
references: Mol Cell Biol. 2006 Mar;26(6):2037-43
references: 16507984
references: PLoS One. 2011 Mar 23;6(3):e17837
references: 21448457
references: Dis Colon Rectum. 2007 May;50(5):611-20
references: 17297554
references: Nucleic Acids Res. 2009 Feb;37(3):e21
references: 19129229
references: Pharmacogenet Genomics. 2009 Feb;19(2):95-102
references: 18987561
references: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):605-13
references: 20142254
references: PLoS One. 2011;6(5):e19687
references: 21602933
references: Heredity (Edinb). 2005 Sep;95(3):221-7
references: 16077740
references: Cancer Causes Control. 2011 Jul;22(7):1061-6
references: 21643930
references: Cancer Res. 2011 Nov 1;71(21):6758-63
references: 22028319
references: Transl Oncol. 2012 Apr;5(2):113-23
references: 22496928
references: Carcinogenesis. 2011 Jun;32(6):866-71
references: 21422235
references: Thromb Res. 2000 Dec 1;100(5):405-7
references: 11150582
references: Hum Mutat. 2010 Sep;31(9):1050-8
references: 20597107
references: Breast Cancer Res Treat. 2010 Apr;120(3):769-75
references: 19543829
references: Mech Ageing Dev. 2000 Nov 15;119(3):89-99
references: 11080530
references: Cancer Lett. 2004 Dec 8;216(1):81-7
references: 15500951
references: Med Clin (Barc). 2007 Jul 7;129(6):218-21
references: 17678604
references: Breast Cancer Res Treat. 2012 Jul;134(1):393-400
references: 22527105
references: Nat Cell Biol. 2012 Dec;14(12):1270-81
references: 23159929
references: J Immunol Methods. 2010 Jan 31;352(1-2):71-80
references: 19837074
references: Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1807-13
references: 22911335
references: Breast Cancer Res Treat. 2007 Mar;102(1):85-101
references: 17080310
references: J Biol Chem. 2012 Jul 6;287(28):23808-18
references: 22645136
references: Cancer Res. 2008 May 15;68(10):3618-23
references: 18483243
references: Int J Mol Epidemiol Genet. 2012;3(3):184-94
references: 23050049
references: Int J Mol Epidemiol Genet. 2011 Jan 1;2(1):19-29
references: 21537398
references: Am J Clin Nutr. 2010 May;91(5):1273-80
references: 20219960
references: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2905-13
references: 16365008
references: Cancer Res. 2010 Apr 15;70(8):3170-6
references: 20395204
references: J Gerontol A Biol Sci Med Sci. 2009 Aug;64(8):860-4
references: 19435951
references: Breast Cancer Res Treat. 2010 May;121(1):147-56
references: 19714462
references: PLoS One. 2010 May 26;5(5):e10837
references: 20520771
references: PLoS Genet. 2011 Jul;7(7):e1002182
references: 21829373
references: Genetics. 2000 Jun;155(2):945-59
references: 10835412
references: Cancer Causes Control. 2010 Jan;21(1):77-82
references: 19784860
references: J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):285-96
references: 15557801
references: Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):E1363-71
references: 21949400
references: Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17312-5
references: 15574496
references: Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1143-52
references: 14652273
references: Gan To Kagaku Ryoho. 2012 Apr;39(4):498-501
references: 22504671
references: Breast Cancer Res Treat. 2012 Aug;134(3):1337-43
references: 22752289
references: Eur J Cancer. 2009 Nov;45(17):3008-16
references: 19766477
references: Carcinogenesis. 2012 Aug;33(8):1512-21
references: 22562547
references: Clin Exp Dermatol. 2009 Jul;34(5):e202-4
references: 19077094
references: Genetics. 2003 Aug;164(4):1567-87
references: 12930761
references: Clin Med Res. 2009 Jun;7(1-2):4-13
references: 19574486
references: Oncol Res. 2011;19(8-9):375-80
references: 22329196